Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension

Journal of the American College of Cardiology

Volumn 46, Issue 3, 2005, Pages 518-523

  Perticone, Francesco ^a,d   Sciacqua, Angela ^a   Maio, Raffaele ^a   Perticone, Maria ^a   Maas, Renke ^b   Boger, Rainer H ^b   Tripepi, Giuseppe ^c   Sesti, Giorgio ^a   Zoccali, Carmine ^c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c CNR Consiglio Nazionale delle Ricerche   (Italy)

^d Policlinico Mater Domini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; ARGININE DERIVATIVE; DIMETHYLARGININE; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM LESION; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STATISTICAL MODEL; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ARGININE; BLOOD PRESSURE DETERMINATION; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; INFUSIONS, INTRA-ARTERIAL; MALE; NITROPRUSSIDE; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 22844443807     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.04.040     Document Type: Article

References (41)

1. J.R. Vane, E.E. Auggard, R.M. Botting Regulatory functions of the vascular endothelium N Engl J Med 323 1990 27 36
2. V. Fuster, L. Badimon, J.J. Badimon, J.H. Chesebro The pathogenesis of coronary artery disease N Engl J Med 326 1992 242 250
3. R. Ross Atherosclerosis an inflammatory disease N Engl J Med 340 1999 115 126
4. R.F. Furchgott, J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
5. J.C. de Graaf, J.D. Banga, S. Moncada, R.M. Palmer, P.G. de Groot, J.J. Sixma Nitric oxide inhibitor of platelet adhesion under flow conditions Circulation 85 1992 2284 2290
6. J.Y. Jeremy, D. Rowe, A.M. Emsley, A.C. Newby Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc Res 43 1999 580 594
7. R.M.J. Palmer, A.G. Ferrige, S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526
8. J.A. Panza, A.A. Quyyumi, J.E. Brush Jr, S.E. Epstein Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension N Engl J Med 323 1990 22 27
9. S. Taddei, A. Virdis, P. Mattei, A. Salvetti Vasodilation to acetylcholine in primary and secondary forms of human hypertension Hypertension 21 1993 929 933
10. A.M. Zeiher, V. Schächinger, J. Minners Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilation function Circulation 92 1995 1094 1100
11. M.T. Johnstone, S.J. Creager, K.M. Scales, J.A. Cusco, B.K. Lee, M.A. Creager Impaired endothelium-dependent coronary arterial vasodilation in patients with insulin-dependent diabetes mellitus Circulation 88 1993 2510 2516
12. M.A. Creager, J.P. Cooke, M.E. Mendelsohn Impaired vasodilation of forearm resistance vessel in hypercholesterolemic humans J Clin Invest 86 1990 228 234
13. F. Perticone, R. Ceravolo, M. Candigliota Obesity and body fat distribution induces endothelial dysfunction by oxidative stress. Protective effect of vitamin C Diabetes 501 2001 159 165
14. F. Perticone, R. Ceravolo, A. Pujia Prognostic significance of endothelial dysfunction in hypertensive patients Circulation 104 2001 191 196
15. T.F. Lüscher, P.M. Vanhoutte The Endothelium Modulator of Cardiovascular Function 1990 CRC Press Boca Raton, FL
16. A.A. Quyyumi Endothelial function in health and disease new insights into the genesis of cardiovascular disease Am J Med 105 1998 32 39S
17. R.J. MacAllister, S.A. Fickling, G.S. Whitley, P. Vallance Metabolism of methylarginines by human vasculature implications for the regulation of nitric oxide synthesis Br J Pharmacol 112 1994 43 48
18. P. Vallance, A. Leone, A. Calver, J. Collier, S. Moncada Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 339 1992 572 575
19. T.M. Lu, Y.A. Ding, H.B. Leu, W.H. Yin, W.H. Sheu, K.M. Chu Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia Am J Cardiol 94 2004 157 161
20. J.P. Cooke, V.J. Dzan Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases Circulation 96 1997 379 382
21. R.H. Boger, S.M. Bode-Boger, W. Thiele, W. Junker, K. Alexander, J.C. Frolich Biochemical evidence for impaired nitric oxide synthase in patients with peripheral arterial occlusive diseases Circulation 95 1997 2068 2074
22. A. Calver, J. Collier, A. Leone, S. Moncada, P. Vallance Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arteriolar bed of healthy volunteers J Hum Hypertens 7 1993 193 194
23. A. Palloshi, G. Fragasso, P. Piatti Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise test, and normal coronary arteries Am J Cardiol 93 2004 930 935
24. A. Surdacki, M. Nowicki, J. Sandmann Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetrical dimethylarginine in men with essential hypertension J Cardiovasc Pharmacol 33 1999 652 658
25. G. Zeng, F.H. Nystrom, L.V. Ravichandran Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells Circulation 101 2000 1539 1545
26. V. Achan, M. Broadhead, M. Malaki Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase Arterioscler Thromb Vasc Biol 23 2003 1455 1459
27. J.P. Cooke Asymmetrical dimethylarginine the Uber marker? Circulation 109 2004 1813 1818
28. R.H. Böger The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor Cardiovasc Res 59 2003 824 833
29. M.C. Stuhlinger, R.K. Oka, E.E. Graf Endothelial dysfunction induced by hyperhomocyst(e)inemia role of asymmetric dimethylarginine Circulation 108 2003 933 938
30. S. Thorne, M.J. Mullen, P. Clarkson, A.E. Donald, J.E. Deanfield Early endothelial dysfunction in adults at risk from atherosclerosis different responses to L-arginine J Am Coll Cardiol 32 1998 110 116
31. A. Fard, C.H. Tuck, J.A. Donis Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes Arterioscler Thromb Vasc Biol 20 2000 2039 2044
32. C.L. Chao, T.L. Kuo, Y.T. Lee Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults Circulation 101 2000 485 490
33. R.H. Böger, S.R. Lentz, S.M. Bode-Boger, H.R. Knapp, W.G. Haynes Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans Clin Sci 100 2001 161 167
34. N. Fujiwara, T. Osanai, T. Kamada, T. Katoh, K. Takahashi, K. Okumura Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension modulation of nitric oxide synthesis by salt intake Circulation 101 2000 856 861
35. T. Osanai, M. Saitoh, S. Sasaki, H. Tomita, T. Matsunaga, K. Okumura Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells Hypertension 42 2003 985 990
36. M.B. Moss, T.M. Brunini, R. Soares De Moura Diminished L-arginine bioavailability in hypertension Clin Sci 107 2004 391 397
37. J.F. Arnal, T. Munzel, R.C. Venema Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability J Clin Invest 95 1995 2565 2572
38. R.G. Bogle, A.R. Baydoun, J.D. Pearson, G.E. Mann Regulation of L-arginine transport and nitric oxide release in superfused porcine aortic endothelial cells J Physiol 490 1996 229 241
39. C.R. Morris, M. Poljakovic, L. Lavrisha, L. Machado, F.A. Kuypers, S.M. Morris Jr. Decreased arginine bioavailability and increased serum arginase activity in asthma Am J Respir Crit Care Med 170 2004 148 153
40. S. Iwata, T. Tsujino, Y. Ikeda Decreased expression of arginase II in the kidneys of Dahl salt-sensitive rats Hypertens Res 25 2002 411-t8
41. S. Rodriguez, L. Richert, A. Berthelot Increased arginase activity in aorta of mineralocorticoid-salt hypertensive rats Clin Exp Hypertens 22 2000 75 85